Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $231 | - | In Stock | |
| 5 mg | $602 | - | In Stock | |
| 10 mg | $943 | - | In Stock | |
| 25 mg | $1,410 | - | In Stock | |
| 50 mg | Preferential | - | In Stock |
| Description | Cantuzumab is a monoclonal antibody that targets the CanAg antigen and possesses antitumor activity; it is used to synthesize the ADC compound cantuzumab mertansine. By binding to CanAg, cantuzumab mediates the endocytosis of the ADC complex into cells, where it cleaves to release the cytotoxic payload, thereby achieving highly efficient and specific tumor killing. |
| Reactivity | Human |
| Verified Activity | HT-1376 cells at 1×10^5 cell/well can bind Cantuzumab. |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | MUC1 |
| Molecular Weight | 147.02 kDa |
| Cas No. | 1204740-23-7 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | Store at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.